Literature DB >> 20042705

Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Richard M Dubinsky1, Janis Miyasaki.   

Abstract

OBJECTIVE: To determine if transcutaneous electric nerve stimulation (TENS) is efficacious in the treatment of pain in neurologic disorders.
METHODS: We performed a systematic literature search of Medline and the Cochrane Library from inception to April 2009.
RESULTS: There are conflicting reports of TENS compared to sham TENS in the treatment of chronic low back pain, with 2 Class II studies showing benefit, but 2 Class I studies and another Class II study not showing benefit. Because the Class I studies are stronger evidence, TENS is established as ineffective for the treatment of chronic low back pain (2 Class I studies). TENS is probably effective in treating painful diabetic neuropathy (2 Class II studies). RECOMMENDATIONS: Transcutaneous electric nerve stimulation (TENS) is not recommended for the treatment of chronic low back pain (Level A). TENS should be considered in the treatment of painful diabetic neuropathy (Level B). Further research into the mechanism of action of TENS is needed, as well as more rigorous studies for determination of efficacy.

Entities:  

Mesh:

Year:  2009        PMID: 20042705     DOI: 10.1212/WNL.0b013e3181c918fc

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

Review 1.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

2.  TENS for pain relief—the power of suggestion.

Authors:  Richard D Wigley
Journal:  Nat Rev Rheumatol       Date:  2010-12       Impact factor: 20.543

Review 3.  Using TENS for pain control: the state of the evidence.

Authors:  Carol G T Vance; Dana L Dailey; Barbara A Rakel; Kathleen A Sluka
Journal:  Pain Manag       Date:  2014-05

4.  Treatment of diabetic sensory polyneuropathy.

Authors:  Lindsay Zilliox; James W Russell
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

5.  Pain: continued uncertainty of TENS' effectiveness for pain relief.

Authors:  Mark I Johnson; Deirdre M Walsh
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

6.  The AAN's role in the development of health insurer coverage policy.

Authors:  Saty Satya-Murti; Katie M Shepard
Journal:  Neurol Clin Pract       Date:  2012-06

7.  Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy.

Authors:  Mitra Tavakoli; Omar Asghar; Uazman Alam; Ioannis N Petropoulos; Hassan Fadavi; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

Review 8.  Role of rehabilitation medicine and physical agents in the treatment of cancer-associated pain.

Authors:  Andrea L Cheville; Jeffrey R Basford
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

9.  [Analgesic efficacy of TENS therapy in patients with gonarthrosis. A prospective, randomised, placebo-controlled, double-blind study].

Authors:  B Gschiel; H Kager; W Pipam; K Weichart; R Likar
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

Review 10.  [Postherpetic neuralgia].

Authors:  G Goßrau
Journal:  Schmerz       Date:  2014-02       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.